All of the following are true regarding vitamin K and the coagulation cascade EXCEPT:

Explanation

## Vitamin K Function and Deficiency Effects ### Correct Statements (Options 0, 1, 2) **Option 0 — Gamma-Glutamyl Carboxylase Cofactor (CORRECT)** **Key Point:** Vitamin K (phylloquinone, K1; menaquinone, K2) is an essential cofactor for gamma-glutamyl carboxylase (GGCX). This enzyme catalyzes the carboxylation of glutamic acid (Glu) residues to gamma-carboxyglutamic acid (Gla) in vitamin K-dependent proteins, creating calcium-binding sites critical for coagulation. **High-Yield:** The reaction: `Glu + O₂ + vitamin K (reduced) → Gla + vitamin K (epoxide)` **Option 1 — Warfarin Mechanism (CORRECT)** **Mnemonic:** **VKOR** = **V**itamin K **O**xide **R**eductase. Warfarin inhibits VKOR, blocking the regeneration of reduced vitamin K from its inactive epoxide form. This depletes the active cofactor pool, impairing carboxylation of new clotting factor molecules. **Clinical Pearl:** Warfarin does NOT directly inhibit clotting factors; it prevents vitamin K recycling, so only newly synthesized factors are affected. This is why warfarin takes 36–72 hours to achieve full anticoagulation (time for existing factors to be cleared). **Option 2 — Vitamin K-Dependent Factors (CORRECT)** **High-Yield:** The four main vitamin K-dependent coagulation factors are: - **Prothrombin (Factor II)** - **Factor VII** - **Factor IX** - **Factor X** Memory aid: **"II, VII, IX, X"** or **"1, 2, 3, 4"** (in Roman numerals). All require Gla residues for: - Calcium binding (essential for assembly on phospholipid membranes) - Phospholipid interaction (the surface on which coagulation cascades occur) ### Incorrect Statement (Option 3) — THE ANSWER **Warning:** This is a classic trap. Vitamin K deficiency does **NOT** impair all coagulation factors equally. The pattern is selective: **Differential Effect by Factor:** | Factor | Synthesis Rate | Plasma Half-Life | Effect of K Deficiency | | --- | --- | --- | --- | | **Factor VII** | Moderate | **Shortest (~6 hrs)** | **Decreases FIRST** | | **Factor II** | Moderate | ~60 hrs | Decreases second | | **Factor IX** | Moderate | ~24 hrs | Decreases third | | **Factor X** | Moderate | ~40 hrs | Decreases last | **Clinical Consequence:** - **PT (measures Factors II, VII, X)** becomes prolonged **early** because Factor VII has the shortest half-life and is depleted first. - **aPTT (measures Factors II, IX, XII)** becomes prolonged **later** because Factor II (longer half-life) is depleted more slowly. - **PT is prolonged BEFORE aPTT** in vitamin K deficiency — this is a pathognomonic pattern. **Key Point:** The sequence of factor depletion depends on **synthesis rate** (all similar) and **plasma half-life** (highly variable). This creates a **disproportionate** and **sequential** pattern of prolongation, NOT a proportional decrease. ### Mnemonic for Vitamin K Deficiency Pattern **"PT before aPTT"** — Factor VII (shortest half-life) is depleted first, prolonging PT. aPTT lags because Factor II has a longer half-life. ### Clinical Pearl In a patient with: - Prolonged PT but normal aPTT → suspect **Factor VII deficiency** or **vitamin K deficiency** (early) - Prolonged PT and aPTT → suspect **vitamin K deficiency** (advanced) or **liver disease** (affects all factors) - Prolonged aPTT but normal PT → suspect **Factor VIII, IX, XI, or XII deficiency** (intrinsic pathway)